• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).

作者信息

Oparil Suzanne, Lewis Cora E

机构信息

From Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, The University of Alabama at Birmingham (S.O.); and Department of Medicine, Division of Preventive Medicine, The University of Alabama at Birmingham (C.E.L.).

出版信息

Circulation. 2016 Nov 1;134(18):1308-1310. doi: 10.1161/CIRCULATIONAHA.116.023263. Epub 2016 Sep 12.

DOI:10.1161/CIRCULATIONAHA.116.023263
PMID:27619922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5089929/
Abstract
摘要

相似文献

1
Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial).具有心血管危险因素的患者是否应将高血压强化治疗至<120/80 mmHg的目标值？来自收缩压干预试验（SPRINT）的正方观点
Circulation. 2016 Nov 1;134(18):1308-1310. doi: 10.1161/CIRCULATIONAHA.116.023263. Epub 2016 Sep 12.
2
Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3).心血管危险因素患者是否应将高血压强化治疗至<120/80 mmHg的目标值？来自HOPE-3试验（心脏结局评估-3）的反对观点
Circulation. 2016 Nov 1;134(18):1311-1313. doi: 10.1161/CIRCULATIONAHA.116.023264. Epub 2016 Sep 12.
3
In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?继收缩压干预试验之后：改善慢性肾脏病高血压管理的新目标？
Nephron. 2017;135(4):287-290. doi: 10.1159/000455130. Epub 2017 Feb 4.
4
Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.血压变异性预测慢性肾脏病不良事件和心血管结局：SPRINT 试验的事后分析。
Am J Hypertens. 2017 Dec 8;31(1):48-52. doi: 10.1093/ajh/hpx128.
5
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.收缩压干预试验（SPRINT）与未来高血压指南中的目标收缩压
Hypertension. 2016 Aug;68(2):318-23. doi: 10.1161/HYPERTENSIONAHA.116.07575. Epub 2016 Jun 27.
6
Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.SPRINT（收缩压干预试验）和 ACCORD（控制糖尿病心血管风险行动）中的收缩压反应：对试验结果不一致的一种可能解释。
J Am Heart Assoc. 2017 Nov 13;6(11):e007509. doi: 10.1161/JAHA.117.007509.
7
BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?高血压的血压目标：既然SPRINT试验结果已出，我们现在该怎么做？
Curr Cardiol Rep. 2016 Oct;18(10):98. doi: 10.1007/s11886-016-0775-0.
8
Multiphasic effects of blood pressure on survival in hemodialysis patients.血压对血液透析患者生存的多相影响。
Kidney Int. 2016 Sep;90(3):674-84. doi: 10.1016/j.kint.2016.05.025.
9
Treatment of Hypertension: Which Goal for Which Patient?高血压的治疗：针对不同患者应设定何种目标？
Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97.
10
Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.使用自动诊室血压测量评估高血压患者的心血管风险与血压控制情况的关系
Hypertension. 2016 Oct;68(4):866-72. doi: 10.1161/HYPERTENSIONAHA.116.07721. Epub 2016 Aug 15.

引用本文的文献

1
Blood pressure targets in adults with hypertension.高血压成人的血压目标。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349. doi: 10.1002/14651858.CD004349.pub3.
2
Risk Factors in Adolescence for the Development of Elevated Blood Pressure and Hypertension in American Indian and Alaskan Native Adults.青少年时期的风险因素与美国印第安人和阿拉斯加原住民成年人高血压的发展。
J Immigr Minor Health. 2021 Aug;23(4):717-724. doi: 10.1007/s10903-020-01130-2. Epub 2020 Nov 28.
3
Approaches for the Management of Resistant Hypertension in 2020.2020 年耐药性高血压的管理方法。
Curr Hypertens Rep. 2020 Jan 8;22(1):3. doi: 10.1007/s11906-019-1013-0.
4
Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.使用心血管疾病患者的自动测量确定最佳治疗期间舒张期血压范围 - SPRINT 试验亚组分析。
J Clin Hypertens (Greenwich). 2019 Jul;21(7):911-918. doi: 10.1111/jch.13581. Epub 2019 Jun 6.
5
Role of Coronary Artery Calcium for Stratifying Cardiovascular Risk in Adults With Hypertension.高血压患者冠状动脉钙积分在心血管风险分层中的作用。
Hypertension. 2019 May;73(5):983-989. doi: 10.1161/HYPERTENSIONAHA.118.12266.
6
Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension.收缩压与老年高血压患者认知能力下降。
Ann Fam Med. 2019 Mar;17(2):100-107. doi: 10.1370/afm.2367.
7
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-old.29个国家的心血管疾病负担以及全科医生对最年长者高血压治疗的决策
Scand J Prim Health Care. 2018 Mar;36(1):89-98. doi: 10.1080/02813432.2018.1426142. Epub 2018 Jan 25.
8
Hypertension highlights during 2016.2016年期间高血压凸显。
Ann Transl Med. 2017 Oct;5(20):404. doi: 10.21037/atm.2017.07.42.
9
Managing Hypertension in Patients Aged 75 Years and Older.管理 75 岁及以上患者的高血压。
Curr Hypertens Rep. 2017 Oct 18;19(11):88. doi: 10.1007/s11906-017-0785-3.
10
Managing Hypertension in the Elderly: What is Different, What is the Same?老年高血压管理：有何不同，有何相同？
Curr Hypertens Rep. 2017 Aug;19(8):67. doi: 10.1007/s11906-017-0764-8.

本文引用的文献

1
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响：一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
2
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.加拿大高血压协会《2016年加拿大高血压教育计划血压测量、诊断、风险评估、预防及治疗指南》
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
3
Generalizability of SPRINT Results to the U.S. Adult Population.收缩压干预试验（SPRINT）结果在美国成年人群中的可推广性。
J Am Coll Cardiol. 2016 Feb 9;67(5):463-72. doi: 10.1016/j.jacc.2015.10.037. Epub 2015 Nov 9.
4
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
5
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.2型糖尿病合并心血管危险因素管理策略的结局：ACCORD随机试验
Diabetes Care. 2014 Jun;37(6):1721-8. doi: 10.2337/dc13-2334. Epub 2014 Mar 4.